LexDanaLexDanabeta
Inventor

Philip Jones

Inventor
Houston, TX, US

Overview

39→
Patents
2010–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 39 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds37%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
A61KPreparations for medical, dental or toiletry purposes22%
C07BGeneral methods of organic chemistry3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G06FElectric digital data processing1%
PatentTitleYear
10,929,373Event failure management202110,851,110Heterocyclic inhibitors of PTPN11202010,800,769Heterocyclic inhibitors of ATR kinase202010,800,774Heterocyclic inhibitors of ATR kinase202010,766,892GLS1 inhibitors for treating disease202010,745,420Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase202010,738,043GLS1 inhibitors for treating disease202010,562,916Substituted quinoxalines as PDE-10 inhibitors202010,428,057Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease201910,421,765Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase201910,392,376Heterocyclic inhibitors of ATR kinase201910,363,248Salts of heterocyclic modulators of HIF activity for treatment of disease201910,344,025GLS1 inhibitors for treating disease201910,280,171Heterocyclic inhibitors of PTPN11201910,208,059Heterocyclic modulators of HIF activity for treatment of disease201910,150,753Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide201810,125,128GLS1 inhibitors for treating disease201810,093,664Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease20189,809,588'GLS1 inhibitors for treating disease'20179,663,504'Salts of heterocyclic modulators of HIF activity for treatment of disease'20179,481,692'Heterocyclic modulators of HIF activity for treatment of disease'20169,115,120'Heterocyclic modulators of HIF activity for treatment of disease'20159,096,598'Azaindoles as Janus kinase inhibitors'20159,018,380'Heterocyclic modulators of HIF activity for treatment of disease'20158,937,077'Bicyclic diamines as janus kinase inhibitors'20158,765,760'[1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases'20148,604,038'Pyrrolidine derived beta 3 adrenergic receptor agonists'20138,470,823'Saturated bicyclic heterocyclic derivatives as SMO antagonists'20138,362,030'Tricyclic derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)'20138,354,413'Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)'20138,268,827'Pyridazinone derivatives as PARP inhibitors'20128,188,084'Pyridinone and pyridazinone derivatives as inhibitors of poly (ADP-ribose) polymerase (PARP)'20128,080,573'Heterocycle substituted amide and sulfur amide derivatives as histone deacetylase (hdac) inhibitors'20118,071,623'Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors'20118,026,265'Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors'20117,977,374'Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors'20117,863,294'Heterocycle derivatives as histone deacetylase (HDAC) inhibitors'20117,834,015'Pyrrolo[1,2-a] pyrazin-1(2H)-one and pyrrolo[1,2-d][1,2,4]triazin-1(2H)-one derivatives as inhibitors of poly(ADP-ribose)polymerase (PARP)'20107,799,825'Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors'2010

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2010–2013Patents assigned to ANGELETTI P IST RICHERCHE BIO (11)· patent assignee history
2010–2013Based in Pomezia, IT· patent location history
2011–2015Patents assigned to JONES PHILIP (10)· patent assignee history
2011–2013Based in Rome, IT· patent location history
2013–2020Based in Houston, TX, US· patent location history
2014–2020Based in Danvers, MA, US· patent location history
2015–2020Patents assigned to UNIV TEXAS (21)· patent assignee history
2016–2019Patents assigned to BOARD OF REGENTS UNIV OF TEXAS SYSTEM (4)· patent assignee history
2019–2020Patents assigned to CHEMPARTNER CORP (5)· patent assignee history
2021Based in Hook, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV TEXAS212015–2020
ANGELETTI P IST RICHERCHE BIO112010–2013
JONES PHILIPself102011–2015
CHEMPARTNER CORP52019–2020
BOARD OF REGENTS UNIV OF TEXAS SYSTEM42016–2019
Locations
LocationPatentsSpan
Houston, Texas, US242013–2020
Rome, IT62011–2013
Pomezia, IT52010–2013
Danvers, Massachusetts, US22014–2020
Hook, GB12021